Explain this page
Arphra AIPlain-English read on Paramount Skydance Corporation Class B Common Stock’s valuationRatios & metrics
Profitability, returns on capital, growth, and credit — all derived from the historical income statement, balance sheet, and cash flow rows in our data warehouse.
Valuation multiples
Price- and EV-based multiples plus shareholder yields. Snapshot at each fiscal year-end from key_metrics (FMP).
ActualEstimate
| In USD | FY 2023 | FY 2024 | FY 2025 | 2026E | 2027E | 2028E | 2029E |
|---|---|---|---|---|---|---|---|
| Headline | |||||||
| Market cap | — | — | — | — | — | — | — |
| Enterprise value | — | — | — | — | — | — | — |
| Multiples | |||||||
| P / E | — | — | — | — | — | — | — |
| P / B | — | — | — | — | — | — | — |
| EV / EBITDA | — | — | — | — | — | — | — |
| EV / Sales | — | — | — | — | — | — | — |
| EV / FCF | — | — | — | — | — | — | — |
| Yields | |||||||
| Earnings yield | — | — | — | — | — | — | — |
| Free cash flow yield | — | — | — | — | — | — | — |
| Dividend yield | — | — | — | — | — | — | — |
Profitability
Margin structure across the last 5 fiscal years
ActualEstimate
| In USD | FY 2023 | FY 2024 | FY 2025 | 2026E | 2027E | 2028E | 2029E |
|---|---|---|---|---|---|---|---|
| Margins | |||||||
| Gross margin | +24.50% | +28.30% | +33.46% | +29.24% | +29.30% | +29.50% | +29.18% |
| Operating margin | -1.52% | +5.50% | -18.04% | -4.76% | -4.65% | -4.71% | -4.70% |
| EBITDA margin | +0.29% | -16.86% | -16.86% | -4.81% | -4.77% | -4.70% | -4.71% |
| EBIT margin | -1.12% | -18.20% | -18.20% | -12.52% | -12.38% | -12.41% | -12.20% |
| Pre-tax margin | -5.44% | -22.14% | -21.14% | -16.50% | -16.60% | -16.60% | -15.85% |
| Net margin | -3.52% | -21.19% | -21.19% | -15.65% | -15.51% | -15.47% | -15.44% |
| Cost structure | |||||||
| Cost of revenue / sales | +75.50% | +71.70% | +66.54% | +73.21% | +70.52% | +72.39% | +70.95% |
| R&D intensity | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| SG&A intensity | +24.43% | +22.79% | +22.79% | +23.63% | +23.34% | +23.94% | +23.86% |
| Effective tax rate | — | — | — | — | — | — | — |
Returns on capital
ROE / ROA / ROC / ROIC over the relevant capital base, plus the 3-step DuPont decomposition of ROE.
ActualEstimate
| In USD | FY 2023 | FY 2024 | FY 2025 | 2026E | 2027E | 2028E | 2029E |
|---|---|---|---|---|---|---|---|
| Returns | |||||||
| Return on equity (ROE) | -4.53% | -36.88% | -48.03% | -26.88% | -25.82% | -26.63% | -26.89% |
| Return on assets (ROA) | -1.95% | -13.41% | -14.28% | -9.68% | -9.53% | -9.41% | -9.69% |
| Return on capital (ROC) | -1.15% | +4.93% | -19.33% | -4.33% | -4.18% | -4.29% | -4.32% |
| Return on invested capital (ROIC) | -0.86% | +3.70% | -14.50% | -3.25% | -3.14% | -3.22% | -3.24% |
| Asset turnover | +55.38% | +63.27% | +67.40% | +61.88% | +61.43% | +60.82% | +62.79% |
| DuPont · ROE decomposition | |||||||
| Net margin | -3.52% | -21.19% | -21.19% | -15.65% | -15.51% | -15.47% | -15.44% |
| Asset turnover (× revenue / assets) | +55.38% | +63.27% | +67.40% | +61.88% | +61.43% | +60.82% | +62.79% |
| Equity multiplier (× assets / equity) | +232.29% | +275.13% | +336.32% | +277.61% | +271.06% | +282.99% | +277.39% |
Activity & efficiency
Turnover ratios and days-outstanding — how efficiently the business converts assets and working capital into sales and cash.
ActualEstimate
| In USD | FY 2023 | FY 2024 | FY 2025 | 2026E | 2027E | 2028E | 2029E |
|---|---|---|---|---|---|---|---|
| Turnover | |||||||
| Asset turnover | 0.55 | 0.63 | 0.67 | 0.62 | 0.61 | 0.61 | 0.63 |
| Fixed-asset turnover | 10.41 | 11.33 | 8.80 | — | — | — | — |
| Inventory turnover | 15.83 | 14.66 | 13.30 | — | — | — | — |
| Receivables turnover | 4.17 | 4.22 | 4.42 | — | — | — | — |
| Payables turnover | 20.35 | 21.98 | 21.45 | — | — | — | — |
| Days outstanding | |||||||
| Days sales outstanding (DSO) | 87.58 | 86.46 | 82.65 | — | — | — | — |
| Days inventory outstanding (DIO) | 23.05 | 24.90 | 27.44 | — | — | — | — |
| Days payables outstanding (DPO) | 17.93 | 16.61 | 17.01 | — | — | — | — |
| Cash conversion cycle | 92.70 | 94.76 | 93.07 | — | — | — | — |
Cash flow quality
How well reported earnings translate into operating and free cash flow, plus reinvestment intensity.
ActualEstimate
| In USD | FY 2023 | FY 2024 | FY 2025 | 2026E | 2027E | 2028E | 2029E |
|---|---|---|---|---|---|---|---|
| Operating CF / Net income | -0.45 | -0.12 | -0.12 | -0.14 | -0.15 | -0.14 | -0.15 |
| FCF / Net income | -0.14 | -0.08 | -0.08 | -0.08 | -0.08 | -0.08 | -0.08 |
| FCF margin | +0.50% | +1.67% | +1.67% | +1.25% | +1.31% | +1.28% | +1.27% |
| OCF margin | +1.60% | +2.57% | +2.57% | +2.20% | +2.25% | +2.23% | +2.27% |
| CapEx / Revenue | +1.11% | +0.90% | +0.90% | +0.96% | +0.98% | +0.95% | +0.97% |
| CapEx / D&A | 0.78 | 0.67 | 0.67 | — | — | — | — |
| Stock-based comp / Revenue | +0.60% | +0.84% | +0.84% | — | — | — | — |
Per-share & shareholder yield
EPS, book value, sales, cash flow and dividends per share — plus payout / retention.
ActualEstimate
| In USD | FY 2023 | FY 2024 | FY 2025 | 2026E | 2027E | 2028E | 2029E |
|---|---|---|---|---|---|---|---|
| EPS · diluted | -1.69 | -9.34 | -9.32 | 1.12 | 1.20 | 1.93 | 1.73 |
| EPS · basic | -1.69 | -9.34 | -9.32 | 1.11 | 1.19 | 1.94 | 1.72 |
| Book value / share | 35.35 | 25.27 | 19.41 | 26.10 | 27.73 | 27.03 | 27.26 |
| Tangible BV / share | 6.05 | 5.83 | 7.60 | 26.10 | 27.73 | 27.03 | 27.26 |
| Sales / share | 45.48 | 44.00 | 44.00 | 44.84 | 46.17 | 46.52 | 47.48 |
| Operating CF / share | 0.73 | 1.13 | 1.13 | 0.98 | 1.04 | 1.04 | 1.08 |
| Free cash flow / share | 0.23 | 0.74 | 0.74 | 0.56 | 0.60 | 0.59 | 0.60 |
| Dividends / share | 0.60 | 0.21 | 0.00 | 0.27 | 0.28 | 0.28 | 0.28 |
| Payout ratio | -37.22% | -2.25% | 0.00% | -3.82% | -3.91% | -3.93% | -3.79% |
| Retention ratio | +137.22% | +102.25% | +100.00% | +103.82% | +103.91% | +103.93% | +103.79% |
Growth
Year-over-year change for headline P&L lines, plus through-cycle CAGR
ActualEstimate
| In USD | FY 2023 | FY 2024 | FY 2025 | 2026E | 2027E | 2028E | 2029E | 6y CAGR |
|---|---|---|---|---|---|---|---|---|
| Top-line | ||||||||
| Revenue · YoY | — | -1.48% | 0.00% | +2.35% | +1.67% | +1.66% | +1.52% | +0.94% |
| Gross profit · YoY | — | +13.79% | +18.27% | -10.57% | +1.86% | +2.37% | +0.40% | +3.93% |
| Profit | ||||||||
| Operating income · YoY | — | +456.54% | -427.67% | +73.00% | +0.69% | -2.92% | -1.32% | — |
| EBITDA · YoY | — | -5894.12% | 0.00% | +70.81% | -0.89% | -0.14% | -1.80% | — |
| Net income · YoY | — | -492.34% | 0.00% | +24.42% | -0.74% | -1.45% | -1.30% | — |
| Operating | ||||||||
| EBIT · YoY | — | -1496.70% | 0.00% | +29.58% | -0.49% | -1.92% | +0.24% | — |
| R&D · YoY | — | — | — | — | — | — | — | — |
| Per-share | ||||||||
| EPS · diluted · YoY | — | -452.66% | +0.21% | +112.03% | +7.48% | +60.28% | -10.42% | — |
| EPS · basic · YoY | — | -452.66% | +0.21% | +111.95% | +6.80% | +63.17% | -11.20% | — |
Credit & leverage
Balance-sheet health + interest coverage + liquidity. Coverage ratios use period-end debt and trailing interest expense.
ActualEstimate
| In USD | FY 2023 | FY 2024 | FY 2025 | 2026E | 2027E | 2028E | 2029E |
|---|---|---|---|---|---|---|---|
| Leverage | |||||||
| Total debt | $16.12B | $15.83B | $14.38B | $15.45B | $15.55B | $15.93B | $16.13B |
| Net debt | $13.66B | $13.17B | $11.1B | $12.65B | $12.71B | $13.06B | $13.15B |
| Net debt / EBITDA | 160.66 | -2.67 | -2.25 | -8.80 | -8.76 | -8.99 | -8.89 |
| Debt / equity | 0.70 | 0.94 | 1.12 | 0.89 | 0.85 | 0.89 | 0.90 |
| Debt / assets | +30.10% | +34.29% | +33.17% | +31.97% | +31.42% | +31.35% | +32.28% |
| Equity / assets | +43.05% | +36.35% | +29.73% | +36.02% | +36.89% | +35.34% | +36.05% |
| Coverage | |||||||
| EBITDA / interest expense | 0.09 | -5.73 | -5.73 | -1.64 | -1.60 | -1.55 | -1.59 |
| Operating income / interest | -0.49 | 1.87 | -6.13 | -1.63 | -1.56 | -1.55 | -1.58 |
| Interest expense | $920M | $860M | $860M | $874.95M | $907.64M | $939.01M | $932.55M |
| Liquidity | |||||||
| Current ratio | 1.32 | 1.30 | 1.26 | — | — | — | — |
| Quick ratio | 0.99 | 0.99 | 0.93 | — | — | — | — |
| Cash ratio | 0.25 | 0.28 | 0.31 | — | — | — | — |
| Working capital | $3.05B | $2.91B | $2.72B | — | — | — | — |
| Working capital / revenue | +10.28% | +9.96% | +9.31% | — | — | — | — |
Methodology. ROE / ROA / ROC use period-end balance-sheet denominators (no average-of- period smoothing). ROIC = Operating Income × (1 − inferred effective tax rate) over invested capital, with the effective tax inferred from net-to-operating income when both are positive and a 25% default otherwise. Net debt / EBITDA, debt ratios, and interest-coverage ratios are calculated point-in-time at each fiscal year-end. TTM = trailing 4 quarters (income / cash flow summed, balance sheet = most-recent quarterly snapshot). Through-cycle CAGR in the Growth panel uses the geometric mean of first-to-last period growth across the window (positive values only).